Literature DB >> 32275976

PD-1, PD-L1, and BIM as Predictors of Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma.

Felix F Kung1, Suzette M Arias-Mejias2, Enrica Quattrocchi2, Sindhuja Sominidi-Damodaran2, Alina G Bridges3, Julia S Lehman3, Amy L Weaver4, Alexander Meves5.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2020        PMID: 32275976      PMCID: PMC7541661          DOI: 10.1016/j.jid.2020.03.948

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


× No keyword cloud information.
  15 in total

1.  Nivolumab in previously untreated melanoma without BRAF mutation.

Authors:  Caroline Robert; Georgina V Long; Benjamin Brady; Caroline Dutriaux; Michele Maio; Laurent Mortier; Jessica C Hassel; Piotr Rutkowski; Catriona McNeil; Ewa Kalinka-Warzocha; Kerry J Savage; Micaela M Hernberg; Celeste Lebbé; Julie Charles; Catalin Mihalcioiu; Vanna Chiarion-Sileni; Cornelia Mauch; Francesco Cognetti; Ana Arance; Henrik Schmidt; Dirk Schadendorf; Helen Gogas; Lotta Lundgren-Eriksson; Christine Horak; Brian Sharkey; Ian M Waxman; Victoria Atkinson; Paolo A Ascierto
Journal:  N Engl J Med       Date:  2014-11-16       Impact factor: 91.245

2.  Rapid leukocyte migration by integrin-independent flowing and squeezing.

Authors:  Tim Lämmermann; Bernhard L Bader; Susan J Monkley; Tim Worbs; Roland Wedlich-Söldner; Karin Hirsch; Markus Keller; Reinhold Förster; David R Critchley; Reinhard Fässler; Michael Sixt
Journal:  Nature       Date:  2008-05-01       Impact factor: 49.962

Review 3.  PD-L1 Expression as a Predictive Biomarker in Cancer Immunotherapy.

Authors:  Sandip Pravin Patel; Razelle Kurzrock
Journal:  Mol Cancer Ther       Date:  2015-02-18       Impact factor: 6.261

4.  PD-L1 expression in melanoma shows marked heterogeneity within and between patients: implications for anti-PD-1/PD-L1 clinical trials.

Authors:  Jason Madore; Ricardo E Vilain; Alexander M Menzies; Hojabr Kakavand; James S Wilmott; Jessica Hyman; Jennifer H Yearley; Richard F Kefford; John F Thompson; Georgina V Long; Peter Hersey; Richard A Scolyer
Journal:  Pigment Cell Melanoma Res       Date:  2014-12-22       Impact factor: 4.693

5.  Overall survival and PD-L1 expression in metastasized malignant melanoma.

Authors:  Jules Gadiot; Anna I Hooijkaas; Andrew D M Kaiser; Harm van Tinteren; Hester van Boven; Christian Blank
Journal:  Cancer       Date:  2010-11-29       Impact factor: 6.860

6.  Final trial report of sentinel-node biopsy versus nodal observation in melanoma.

Authors:  Donald L Morton; John F Thompson; Alistair J Cochran; Nicola Mozzillo; Omgo E Nieweg; Daniel F Roses; Harold J Hoekstra; Constantine P Karakousis; Christopher A Puleo; Brendon J Coventry; Mohammed Kashani-Sabet; B Mark Smithers; Eberhard Paul; William G Kraybill; J Gregory McKinnon; He-Jing Wang; Robert Elashoff; Mark B Faries
Journal:  N Engl J Med       Date:  2014-02-13       Impact factor: 91.245

7.  T cell Bim levels reflect responses to anti-PD-1 cancer therapy.

Authors:  Roxana S Dronca; Xin Liu; Susan M Harrington; Lingling Chen; Siyu Cao; Lisa A Kottschade; Robert R McWilliams; Matthew S Block; Wendy K Nevala; Michael A Thompson; Aaron S Mansfield; Sean S Park; Svetomir N Markovic; Haidong Dong
Journal:  JCI Insight       Date:  2016-05-05

Review 8.  The role of integrins in melanoma: a review.

Authors:  Suzette M Arias-Mejias; Katerina Y Warda; Enrica Quattrocchi; Hector Alonso-Quinones; Sindhuja Sominidi-Damodaran; Alexander Meves
Journal:  Int J Dermatol       Date:  2020-03-10       Impact factor: 2.736

9.  Involvement of PD-L1 on tumor cells in the escape from host immune system and tumor immunotherapy by PD-L1 blockade.

Authors:  Yoshiko Iwai; Masayoshi Ishida; Yoshimasa Tanaka; Taku Okazaki; Tasuku Honjo; Nagahiro Minato
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-06       Impact factor: 11.205

10.  Model Combining Tumor Molecular and Clinicopathologic Risk Factors Predicts Sentinel Lymph Node Metastasis in Primary Cutaneous Melanoma.

Authors:  Domenico Bellomo; Suzette M Arias-Mejias; Chandru Ramana; Joel B Heim; Enrica Quattrocchi; Sindhuja Sominidi-Damodaran; Alina G Bridges; Julia S Lehman; Tina J Hieken; James W Jakub; Mark R Pittelkow; David J DiCaudo; Barbara A Pockaj; Jason C Sluzevich; Mark A Cappel; Sanjay P Bagaria; Charles Perniciaro; Félicia J Tjien-Fooh; Martin H van Vliet; Jvalini Dwarkasing; Alexander Meves
Journal:  JCO Precis Oncol       Date:  2020-04-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.